Neuroscience
Neurotransmitter receptors function via various G-protein coupled and G-protein independent mechanisms that activate downstream intracellular signaling pathways such as cAMP/PKA, PI3K/AKT, phospholipase A2, and phospholipase C pathways. For instance, dopamine receptors act through adenylate cyclase to activate PKA and other signaling molecules, thereby mediate gene expression through the actions of CREB and other transcription factors. Other neurotransmitters such as NMDAR or AMPAR are associated with ion channels that control flux of Ca2+ and Na+, thus propagating the action potential across the post-synaptic neuron.
Dysfunctions in GABAergic/glutamatergic/serotonergic/dopaminergic pathways result in a broad range of neurological disorders such as chronic pain, neurodegenerative diseases, and insomnia, as well as mental disorders including schizophrenia, bipolar disorder, depression, and addiction.
-
A2700 10Panx1 CitationTarget: Gap JunctionsSummary: Panx-1 mimetic inhibitor
-
A2701 Scrambled 10PanxSummary: Panx-1 mimetic inhibitory peptide, blocks pannexin-1 gap junctions
-
A3136 A-740003Target: P2X ReceptorsSummary: P2X7 receptor antagonist
-
A3138 A-867744Summary: Allosteric Modulator
-
A3142 Acamprosate calciumSummary: GABA receptor agonist and modulator of glutamatergic systems
-
A3157 AlosetronSummary: 5-HT3 receptor antagonist
-
A3159 Alosetron HydrochlorideSummary: 5-HT3 receptor antagonist,potent and highly selective
-
A3192 Asenapine hydrochlorideSummary: Atypical antipsychotic
-
A3239 B-HT 920Summary: D2 receptor agonist
-
A3241 BilobalideSummary: Neuroprotective agent